Universal Financial Statements From 2010 to 2026
| IBOGF Stock | USD 0 0 23.64% |
Check Universal Ibogaine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Universal Ibogaine's main balance sheet or income statement drivers, such as , as well as many indicators such as . Universal financial statements analysis is a perfect complement when working with Universal Ibogaine Valuation or Volatility modules.
Universal |
Universal Ibogaine Company Operating Margin Analysis
Universal Ibogaine's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Universal Ibogaine Operating Margin | (4.29) % |
Most of Universal Ibogaine's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Universal Ibogaine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Universal Ibogaine has an Operating Margin of -4.2917%. This is 87.77% lower than that of the Healthcare sector and 96.17% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 22.11% lower than that of the firm.
Universal Ibogaine Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Universal Ibogaine's current stock value. Our valuation model uses many indicators to compare Universal Ibogaine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Universal Ibogaine competition to find correlations between indicators driving Universal Ibogaine's intrinsic value. More Info.Universal Ibogaine is rated fifth overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Universal Ibogaine's earnings, one of the primary drivers of an investment's value.About Universal Ibogaine Financial Statements
Universal Ibogaine stakeholders use historical fundamental indicators, such as Universal Ibogaine's revenue or net income, to determine how well the company is positioned to perform in the future. Although Universal Ibogaine investors may analyze each financial statement separately, they are all interrelated. For example, changes in Universal Ibogaine's assets and liabilities are reflected in the revenues and expenses on Universal Ibogaine's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Universal Ibogaine. Please read more on our technical analysis and fundamental analysis pages.
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Universal Pink Sheet
Universal Ibogaine financial ratios help investors to determine whether Universal Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Universal with respect to the benefits of owning Universal Ibogaine security.